Skip to main content
SpringerLink
Log in

Fetal infections: Rubella, HIV, HCV, HBV, and Human Parvovirus B19

  • Chapter
Neonatology

  • 353 Accesses

Abstract

Rubella: Salient Points

  • Congenital rubella (CR) infection leads to damage in over 80% of fetuses during the first trimester of pregnancy, in 25–34% of cases in the second trimester, while no malformations occur in the third trimester.

  • CR syndrome (CRS) is characterized by the combination of cardiac, ocular, and hearing defects, although any organ may be affected leading to long-term disabilities.

  • To prevent CRS it is essential to verify before or during pregnancy, that all women have natural or vaccine-induced immunity to the rubella virus.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Robertson SE, Featherstone DA, Gacic-Dobo M et al (2003) Rubella and congenital rubella syndrome: global update. Pan Am J Public Health 14: 306–315

    Article  Google Scholar 

  2. Duszak RS (2009) Congenital rubella syndrome-major review. Optometry 80: 36–43

    Article  PubMed  Google Scholar 

  3. Best JM (2007) Rubella. Semin Fetal Neonatal Med 12: 182–192

    Article  Google Scholar 

  4. Kourtis AP, Schmid CH, Jamieson DJ, Lau J (2007) Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis. AIDS 21: 607–615

    Article  PubMed  CAS  Google Scholar 

  5. Centers for Disease Control and Prevention (1994) Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR Recomm Rep 43: 1–20

    Google Scholar 

  6. European Collaborative Study (2005) Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis 40: 458–465

    Article  Google Scholar 

  7. Perinatal HIV Guidelines Working Group (2009) Recommendations for use of antiretroviral drugs in pregnant HIV-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. http://aidsinfo.nih.gov/ContentFiles/ PerinatalGL.pdf

    Google Scholar 

  8. Chiappini E, Galli L, Gabiano C et al (2006) Early triple therapy vs mono or dual therapy for children with perinatal HIV infection. JAMA 295: 626–628

    Article  PubMed  CAS  Google Scholar 

  9. John-Stewart GC (2009) Strategic approaches to decrease breast milk transmission of HIV-1: the importance of small things. J Infect Dis 200: 1487–1489

    Article  PubMed  CAS  Google Scholar 

  10. Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children (2009) Guidelines for the use of antiretroviral agents in pediatric HIV infection. http://aidsinfo.nih.gov/ContentFiles/PediatricGuidelines.pdf

    Google Scholar 

  11. Centers for Disease Control and Prevention (1999) Guidelines for national human immunodeficiency virus case surveillance, including monitoring for human immunodeficiency virus infection and acquired immunodeficiency syndrome. MMWR Recomm Rep 48: 1–13

    Google Scholar 

  12. Mofenson LM, Brady MT, Danner SP et al (2009) Guidelines for the prevention and treatment of opportunistic infections among HIV-exposed and HIV-infected children. MMWR Recomm Rep 58: 1–166

    PubMed  Google Scholar 

  13. Pembrey L, Newell ML, Tovo PA; EPHN Collaborators (2005) The management of HCV infected pregnant women and their children European paediatric HCV network. J Hepatol 43: 515–525

    Article  PubMed  Google Scholar 

  14. Indolfi G, Resti M (2009) Perinatal transmission of hepatitis C virus infection. J Med Virol 81: 836–843

    Article  PubMed  Google Scholar 

  15. Tovo PA, Lazier L, Versace A (2005) Hepatitis B virus and hepatitis C virus infections in children. Curr Opin Infect Dis 18: 261–266

    Article  PubMed  Google Scholar 

  16. Polywka S, Pembrey L, Tovo PA, Newell ML (2006) Accuracy of HCV-RNA PCR test for diagnosis or exclusion of vertically acquired HCV infection. J Med Virol 78: 305–310

    Article  PubMed  CAS  Google Scholar 

  17. Davidson SM, Mieli-Vergani G, Sira J, Kelly DA (2006) Perinatal hepatitis C virus infection: diagnosis and management. Arch Dis Child 91: 781–785

    Article  Google Scholar 

  18. Davidson SM, Kelly DA (2008) Management strategies for hepatitis C virus infection in children. Pediatr Drugs 10: 357–365

    Article  Google Scholar 

  19. Jara P, Hierro L, de la Vega A et al (2008) Efficacy and safety of peginterferon-alpha2b and ribavirin combination therapy in children with chronic hepatitis C infection. Pediatr Infect Dis J 27: 142–148

    PubMed  Google Scholar 

  20. Hsu EK, Murray KF (2008) Hepatitis B and C in children. Nat Clin Pract Gastroenterol Hepatol 5: 311–320

    Article  PubMed  Google Scholar 

  21. Haber BA, Block JM, Jonas MM et al (2009) Recommendations for screening, monitoring and referral of pediatric chronic hepatitis B. Pediatrics 124: 1007–1014

    Article  Google Scholar 

  22. Kurbegov AC, Sokol RJ (2009) Hepatitis B therapy in children. Expert Rev Gastroenterol Hepatol 3: 39–49

    Article  PubMed  CAS  Google Scholar 

  23. de Jong EP, de Haan TR, Kroes AC et al (2006) Parvovirus B19 infection in pregnancy. J Clin Virol 36: 1–7

    Article  PubMed  Google Scholar 

  24. Heegaard ED, Brown KE (2002) Human Parvovirus B19. Clin Microbiol Rev 15: 485–505

    Article  PubMed  Google Scholar 

  25. www.hepfi.org/pdfs/PegIntron%20and%20Rebetol%20FDA%20Approved_for%20Pediatric%20HCV%2012.12.08.pdf

    Google Scholar 

  26. Pawlowska M, Halota W (2007) Rapid viral response during treatment of chronic hepatitis B with pegylated interferon alfa-2a in children–preliminary report. Przegl Epidemiol 61: 427–431

    PubMed  Google Scholar 

  27. Sokal EM, Conjeevaram HS, Roberts EA et al (1998) Interferon alfa therapy for chronic hepatitis B in children: a multinational randomized controlled trial. Gastroenterology 114: 988–995

    Article  PubMed  CAS  Google Scholar 

  28. Jonas M, Mizerski J, Badia IB et al (2002) Clinical trial of lamivudine in children with chronic hepatitis B. N Engl J Med 346: 1706–1713

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, University of Turin, Turin, Italy

    Pier-Angelo Tovo

Authors
  1. Pier-Angelo Tovo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stefania Bezzio
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Clara Gabiano
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Pediatrics, Obstetrics and Reproductive Medicine, Division of Neonatology, University of Siena General Hospital S. Maria alle Scotte Azienda Ospedaliera Universitaria Senese, Siena, Italy

    Giuseppe Buonocore (Professor of Pediatrics and Neonatology, Head of School of Pediatrics) (Professor of Pediatrics and Neonatology, Head of School of Pediatrics)

  2. University of Siena, Siena, Italy

    Rodolfo Bracci (Formerly Professor of Pediatrics and Head of Department of Pediatrics, Obstetrics and Reproductive Medicine) (Formerly Professor of Pediatrics and Head of Department of Pediatrics, Obstetrics and Reproductive Medicine)

  3. University of Liverpool, UK

    Michael Weindling (Professor of Perinatal Medicine, Director of Postgraduate Research, Head of School of Paediatrics Mersey Deanery) (Professor of Perinatal Medicine, Director of Postgraduate Research, Head of School of Paediatrics Mersey Deanery)

  4. Department of Women’s and Children’s Health, Institute of Translational Medicine, Liverpool, UK

    Michael Weindling (Professor of Perinatal Medicine, Director of Postgraduate Research, Head of School of Paediatrics Mersey Deanery) (Professor of Perinatal Medicine, Director of Postgraduate Research, Head of School of Paediatrics Mersey Deanery)

  5. Liverpool Women’s Hospital, Liverpool, UK

    Michael Weindling (Professor of Perinatal Medicine, Director of Postgraduate Research, Head of School of Paediatrics Mersey Deanery) (Professor of Perinatal Medicine, Director of Postgraduate Research, Head of School of Paediatrics Mersey Deanery)

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Italia

About this chapter

Cite this chapter

Tovo, PA., Bezzio, S., Gabiano, C. (2012). Fetal infections: Rubella, HIV, HCV, HBV, and Human Parvovirus B19. In: Buonocore, G., Bracci, R., Weindling, M. (eds) Neonatology. Springer, Milano. https://doi.org/10.1007/978-88-470-1405-3_113

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-1405-3_113

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-1404-6

  • Online ISBN: 978-88-470-1405-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation